JAMA Network June 3, 2024
Gregory Curfman

A New JAMA Series and Call for Papers

Randomized clinical trials remain the cornerstone of evidence-based medicine. As a leading medical journal publishing the science that advances the clinical care of patients and the health of the public, JAMA is committed to the publication of clinical trials, as well as promoting the discourse on how clinical trial evidence can best serve the needs of patients and clinicians.

In autumn of 2023, JAMA hosted its inaugural in-person JAMA Summit1 on the topic of randomized clinical trials and the challenges and opportunities to improve their design and conduct to be most responsive to the needs of clinical practice. The Special Communication published in JAMA,2 “The Integration of Clinical Trials With the Practice...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Clinical Trials, Physician, Provider, Trends
AI Teaches Surgery; AI Quality Registry; AI Matches Patients With Trials
New NIH tool uses genAI to connect volunteers with clinical trials
Medtronic, Tempus testing AI to find potential TAVR patients
Legal and ethical challenges in AI-driven clinical trials
Biohaven muscle drug misses goal of SMA study, but advances in obesity

Share This Article